New ophthalmic decongestant, tetrahydrozoline hydrochloride; clinical use in 1,156 patients with conjunctival irritation.
D003231:Conjunctivitis / Q000628:therapy*; D005128:Eye Diseases; D006801:Humans; D006967:Hypersensitivity; D007093:Imidazoles; D014663:Nasal Decongestants; D013566:Sympathomimetics / Q000627:therapeutic use*
D007093:Imidazoles; D014663:Nasal Decongestants; D013566:Sympathomimetics; C005810:tetrahydrozoline
ALLERGY/manifestations; CONJUNCTIVITIS/therapy; SYMPATHOMIMETICS/therapeutic use